Questionnaire

Dear Valued Customer,

We highly value your continued support of DRG products and services. In the context of improving our overall customer satisfaction and providing you with compelling and exciting new products, we invite you to complete this short questionnaire.
I would like to confirm that all survey responses and feedback will be kept confidential and may be completed anonymously.

Thank you very much for your cooperation!
Eric van Bladel, COO

Company Name*
Street*
ZIP Code, City*
Phone*
Fax
Email*
Website*
In one or two sentences describe your company?
Where did you first hear about DRG, or buy our products?
- Google
- Colleague
- Trade Show
- Other
How would you describe us to a colleague?
How likely are you to recommend us to a colleague on a scale of 1 (not at all) to 5 (very likely)? Explain why.
What types of new diagnostic testing technologies do you see and find compelling to explore or research further?
What are the products or technologies that you would like to see offered?
What are your biggest every day challenges involving Diagnostics?
What are the top 2-3 things that persuaded you to use our products?
What are the top 2-3 things that nearly stopped you from buying our products?
What could we have done to make your decision easier to buy from us?

News and Updates

Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL

by Oleg Vishnevski | Apr 8, 2021 | News, Products

Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level

Estimating the Burden of Iron Deficiency

by Oleg Vishnevski | Jan 26, 2021 | Products

Background: Iron deficiency (ID) is a major public health burden in African children and accurate prevalence Abstract Background and Objective Iron deficiency (ID) is a major public health burden in African children and accurate prevalence estimates are...

Early postnatal hypoferremia in low birthweight, preterm babies

by Oleg Vishnevski | Jan 21, 2021 | Products

Early postnatal hypoferremia in low birthweight and preterm babies: A prospective cohort study in hospital-delivered Gambian neonates Abstract Background Neonates, particularly those born preterm (PTB) and with low birthweight (LBW), are especially susceptible...

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.